LeilTarek A. Leil, PhD
Group Director – Quantitative Clinical Pharmacology
Clinical Pharmacology & Pharmacometrics

Room E.2140C
Rt. 206 & Province Line Road
Princeton, NJ 08540-4000
Tel: (609) 252-6502
Email: tarek.leil@bms.com

Tarek Leil is currently the head of the Quantitative Clinical Pharmacology (QCP) group within Clinical Pharmacology and Pharmacometrics (CP&P) at Bristol-Myers Squibb (BMS). The QCP group at BMS uses model based approaches, including quantitative systems pharmacology (QSP), physiologically based PK (PBPK), and model-based meta-analysis (MBMA), to integrate clinical and non-clinical data using models that summarize knowledge and generate actionable predictions. These predictions can be used to help with decision making in drug discovery and clinical development, to optimize the design of patient clinical trials, and to facilitate communications with regulatory authorities. Prior to joining BMS in 2011, Dr. Leil worked at Pfizer in the Department of Clinical Pharmacology. Dr. Leil and the QCP group have numerous recent publications and presentations demonstrating the utility of Pharmacometrics and Systems Pharmacology in Pharmaceutical R&D.